ID

23801

Beskrivning

Dietary Intervention and Exercise Training (DIET) in Moderate to Severe Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00581269

Länk

https://clinicaltrials.gov/show/NCT00581269

Nyckelord

Versioner (1)
  1. 2017-07-14 2017-07-14 -
Uppladdad den

14 juli 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Chronic Kidney Disease NCT00581269

Engelsk

Eligibility Chronic Kidney Disease NCT00581269

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with stage iii-iv (estimated gfr 20-59 min/ml) chronic kidney disease measured by mdrd formula.
Beskrivning

Chronic Kidney Disease Stage | MDRD formula eGFR

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1561643
UMLS CUI [1,2]
C0699749
UMLS CUI [2,1]
C3839656
UMLS CUI [2,2]
C3811844
2. bmi ≥ 30 kg/m2
Beskrivning

Body mass index

Datatyp

boolean

Alias
UMLS CUI [1]
C1305855
3. age > 18 or < 65 years.
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
4. life expectancy greater than one year.
Beskrivning

Life Expectancy

Datatyp

boolean

Alias
UMLS CUI [1]
C0023671
5. ability to understand and provide informed consent for participation in the study.
Beskrivning

Informed Consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. active inflammatory disease such as: aids (hiv seropositivity is not an exclusion criteria), active hepatitis c or b, active gout, other active inflammatory diseases.
Beskrivning

Inflammatory disorder | AIDS | HIV Seropositivity Excluded | Hepatitis C | Hepatitis B | Gout

Datatyp

boolean

Alias
UMLS CUI [1]
C1290884
UMLS CUI [2]
C0001175
UMLS CUI [3,1]
C0019699
UMLS CUI [3,2]
C2828389
UMLS CUI [4]
C0019196
UMLS CUI [5]
C0019163
UMLS CUI [6]
C0018099
2. active malignancy excluding basal or squamous cell carcinoma of the skin.
Beskrivning

Malignant Neoplasms | Basal cell carcinoma | Squamous cell carcinoma of skin

Datatyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0553723
3. patients suffering from type i diabetes mellitus
Beskrivning

Diabetes Mellitus, Insulin-Dependent

Datatyp

boolean

Alias
UMLS CUI [1]
C0011854
4. patients with reduced daily caloric intake at baseline (≤ 2000 kcal/day) or malnutrition.
Beskrivning

Calorie intake per day Reduced | Malnutrition

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2095644
UMLS CUI [1,2]
C0392756
UMLS CUI [2]
C0162429
5. patients who are already on a consistent and rigorous exercise regimen.
Beskrivning

Exercise regime Consistent Strenuous

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0454291
UMLS CUI [1,2]
C0332290
UMLS CUI [1,3]
C1514989
6. gastrointestinal dysfunction requiring parental nutrition.
Beskrivning

Gastrointestinal dysfunction | Parenteral Nutrition Patient need for

Datatyp

boolean

Alias
UMLS CUI [1]
C0679407
UMLS CUI [2,1]
C0030547
UMLS CUI [2,2]
C0686904
7. history of functional kidney transplant < 6 months prior to study entry.
Beskrivning

Kidney Transplantation Functional

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0022671
UMLS CUI [1,2]
C0205245
8. anticipated live donor kidney transplant over study duration.
Beskrivning

Live donor renal transplant Expected

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0401177
UMLS CUI [1,2]
C1517001
9. patients taking anti-inflammatory medication except aspirin < 325mg/day over the past 30 days.
Beskrivning

Anti-Inflammatory Agents | Aspirin

Datatyp

boolean

Alias
UMLS CUI [1]
C0003209
UMLS CUI [2]
C0004057
10. patients taking vitamin e supplements > 60 iu/day, vitamin c > 500mg/day over the past 30days.
Beskrivning

Vitamin E supplement U/day | Ascorbic Acid U/day

Datatyp

boolean

Alias
UMLS CUI [1,1]
C3661607
UMLS CUI [1,2]
C0456683
UMLS CUI [2,1]
C0003968
UMLS CUI [2,2]
C0456683
11. patients taking any prednisone therapy.
Beskrivning

Prednisone

Datatyp

boolean

Alias
UMLS CUI [1]
C0032952
12. hospital admission within the last 30 days.
Beskrivning

Hospital admission

Datatyp

boolean

Alias
UMLS CUI [1]
C0184666
13. on experimental drug protocols.
Beskrivning

Investigational New Drugs

Datatyp

boolean

Alias
UMLS CUI [1]
C0013230
14. significant cardiac or vascular disease (symptomatic disease; cv event(s) within the last year; significant occlusive atherosclerotic disease or ischemic disease on non-invasive or invasive diagnostic procedures).
Beskrivning

Heart Disease | Vascular Disease | Disease Symptomatic | Cardiovascular event | Atherosclerotic occlusive disease | Ischemia | Diagnosis, Noninvasive | Diagnostic procedure Invasive

Datatyp

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0042373
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0231220
UMLS CUI [4]
C1320716
UMLS CUI [5]
C0543822
UMLS CUI [6]
C0022116
UMLS CUI [7]
C0259832
UMLS CUI [8,1]
C0430022
UMLS CUI [8,2]
C0205281
15. significant physical disability or immobility (joint disease, joint replacement, muscular disorders).
Beskrivning

Physical disability | Immobility | Arthropathy | Replacement; joint | Myopathy

Datatyp

boolean

Alias
UMLS CUI [1]
C0520817
UMLS CUI [2]
C0231441
UMLS CUI [3]
C0022408
UMLS CUI [4]
C1442800
UMLS CUI [5]
C0026848
Tillbaka till toppen

Similar models

Eligibility Chronic Kidney Disease NCT00581269

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Kidney Disease Stage | MDRD formula eGFR
Item
1. patients with stage iii-iv (estimated gfr 20-59 min/ml) chronic kidney disease measured by mdrd formula.
boolean
C1561643 (UMLS CUI [1,1])
C0699749 (UMLS CUI [1,2])
C3839656 (UMLS CUI [2,1])
C3811844 (UMLS CUI [2,2])
Body mass index
Item
2. bmi ≥ 30 kg/m2
boolean
C1305855 (UMLS CUI [1])
Age
Item
3. age > 18 or < 65 years.
boolean
C0001779 (UMLS CUI [1])
Life Expectancy
Item
4. life expectancy greater than one year.
boolean
C0023671 (UMLS CUI [1])
Informed Consent
Item
5. ability to understand and provide informed consent for participation in the study.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Inflammatory disorder | AIDS | HIV Seropositivity Excluded | Hepatitis C | Hepatitis B | Gout
Item
1. active inflammatory disease such as: aids (hiv seropositivity is not an exclusion criteria), active hepatitis c or b, active gout, other active inflammatory diseases.
boolean
C1290884 (UMLS CUI [1])
C0001175 (UMLS CUI [2])
C0019699 (UMLS CUI [3,1])
C2828389 (UMLS CUI [3,2])
C0019196 (UMLS CUI [4])
C0019163 (UMLS CUI [5])
C0018099 (UMLS CUI [6])
Malignant Neoplasms | Basal cell carcinoma | Squamous cell carcinoma of skin
Item
2. active malignancy excluding basal or squamous cell carcinoma of the skin.
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
Diabetes Mellitus, Insulin-Dependent
Item
3. patients suffering from type i diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Calorie intake per day Reduced | Malnutrition
Item
4. patients with reduced daily caloric intake at baseline (≤ 2000 kcal/day) or malnutrition.
boolean
C2095644 (UMLS CUI [1,1])
C0392756 (UMLS CUI [1,2])
C0162429 (UMLS CUI [2])
Exercise regime Consistent Strenuous
Item
5. patients who are already on a consistent and rigorous exercise regimen.
boolean
C0454291 (UMLS CUI [1,1])
C0332290 (UMLS CUI [1,2])
C1514989 (UMLS CUI [1,3])
Gastrointestinal dysfunction | Parenteral Nutrition Patient need for
Item
6. gastrointestinal dysfunction requiring parental nutrition.
boolean
C0679407 (UMLS CUI [1])
C0030547 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
Kidney Transplantation Functional
Item
7. history of functional kidney transplant < 6 months prior to study entry.
boolean
C0022671 (UMLS CUI [1,1])
C0205245 (UMLS CUI [1,2])
Live donor renal transplant Expected
Item
8. anticipated live donor kidney transplant over study duration.
boolean
C0401177 (UMLS CUI [1,1])
C1517001 (UMLS CUI [1,2])
Anti-Inflammatory Agents | Aspirin
Item
9. patients taking anti-inflammatory medication except aspirin < 325mg/day over the past 30 days.
boolean
C0003209 (UMLS CUI [1])
C0004057 (UMLS CUI [2])
Vitamin E supplement U/day | Ascorbic Acid U/day
Item
10. patients taking vitamin e supplements > 60 iu/day, vitamin c > 500mg/day over the past 30days.
boolean
C3661607 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0003968 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
Prednisone
Item
11. patients taking any prednisone therapy.
boolean
C0032952 (UMLS CUI [1])
Hospital admission
Item
12. hospital admission within the last 30 days.
boolean
C0184666 (UMLS CUI [1])
Investigational New Drugs
Item
13. on experimental drug protocols.
boolean
C0013230 (UMLS CUI [1])
Heart Disease | Vascular Disease | Disease Symptomatic | Cardiovascular event | Atherosclerotic occlusive disease | Ischemia | Diagnosis, Noninvasive | Diagnostic procedure Invasive
Item
14. significant cardiac or vascular disease (symptomatic disease; cv event(s) within the last year; significant occlusive atherosclerotic disease or ischemic disease on non-invasive or invasive diagnostic procedures).
boolean
C0018799 (UMLS CUI [1])
C0042373 (UMLS CUI [2])
C0012634 (UMLS CUI [3,1])
C0231220 (UMLS CUI [3,2])
C1320716 (UMLS CUI [4])
C0543822 (UMLS CUI [5])
C0022116 (UMLS CUI [6])
C0259832 (UMLS CUI [7])
C0430022 (UMLS CUI [8,1])
C0205281 (UMLS CUI [8,2])
Physical disability | Immobility | Arthropathy | Replacement; joint | Myopathy
Item
15. significant physical disability or immobility (joint disease, joint replacement, muscular disorders).
boolean
C0520817 (UMLS CUI [1])
C0231441 (UMLS CUI [2])
C0022408 (UMLS CUI [3])
C1442800 (UMLS CUI [4])
C0026848 (UMLS CUI [5])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial